Ibacitabine

Ibacitabine

SCHEMBL9710365

Nc1nc(=O)[nH]cc1I.Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 6/20 0.54
TK1 P04183 2/20 0.53
ADRB1 P08588 1/20 0.53
DNMT3B Q9UBC3 2/20 0.49
FPR2 P25090 1/20 0.44
LMNA P02545 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PNP P00491 1/20 0.42
TP53 P04637 1/20 0.42
HTT P42858 1/20 0.42
PDE4D Q08499 1/20 0.42
PDE3A Q14432 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ibacitabine SCHEMBL21423094 0.91 DNMT1 (0.63) DNMT1TK1ADRB1DNMT3BFPR2
Ibacitabine SCHEMBL225403 0.91 DNMT1 (0.63) DNMT1TK1ADRB1DNMT3BFPR2
Ibacitabine SCHEMBL225402 0.91 DNMT1 (0.63) DNMT1TK1ADRB1DNMT3BFPR2
Ibacitabine SCHEMBL244921 0.91 DNMT1 (0.63) DNMT1TK1ADRB1DNMT3BFPR2
Ibacitabine SCHEMBL13812993 0.91 DNMT1 (0.63) DNMT1TK1ADRB1DNMT3BFPR2
Ibacitabine SCHEMBL887475 0.91 DNMT1 (0.63) DNMT1TK1ADRB1DNMT3BFPR2
Ibacitabine SCHEMBL5981939 0.91 DNMT1 (0.63) DNMT1TK1ADRB1DNMT3BFPR2
Ibacitabine SCHEMBL5981937 0.91 DNMT1 (0.63) DNMT1TK1ADRB1DNMT3BFPR2
SCHEMBL1635376 0.83 DNMT1 (0.52) DNMT1TK1ADRB1DNMT3BFPR2
SCHEMBL1635378 0.83 DNMT1 (0.52) DNMT1TK1ADRB1DNMT3BFPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992020816-A1 DETERMINATION OF PRODRUGS METABOLIZABLE BY THE LIVER AND THERAPEUTIC USE THEREOF YALE UNIVERSITY (US) 1992-11-26 WO disclosed